Patent details
301019 Product Name: lisdexamfetamine, desgewenst in de vorm van een mesylaat- of hydrochloridezout daarvan
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 301019
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1644019
- Status:
- SPC in force
- Application number:
- 301019
- Procedural language:
- Dutch
- First Applicant Residence Country:
- United States of America (US)
Marketing Authorization
1
- Marketing Authorization Number:
- RVG 124498
- Marketing Authorization Type:
- National/EU
- Marketing Authorization Date:
- 28/05/2019
- Marketing Authorization Country:
- Netherlands (NL)
2
- Marketing Authorization Number:
- PL 08081/0050-52
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 01/02/2013
- Marketing Authorization Country:
- United Kingdom (GB)
Dates
- Filing date:
- 26/11/2019
- First Marketing Authorization date:
- 01/02/2013
- Grant date:
- 29/07/2020
- Activation date:
- 01/06/2024
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 03/12/2019
- SPC/SPC Extension Expiration Date:
- 31/01/2028
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 16/05/2023
- Name:
- Takeda Pharmaceuticals U.S.A. Inc.
- Address:
- 95 Hayden Avenue, 02421, Lexington, MA, United States of America (US)
Historical Applicant/holder
- From:
- 25/05/2022
- To:
- 16/05/2023
- Name:
- Takeda Pharmaceutical Company Limited
- Address:
- 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan (JP)
- From:
- 26/11/2019
- To:
- 25/05/2022
- Name:
- Shire LLC
- Address:
- 9200 Brookfield Court, FLORENCE, KY 41042, United States of America (US)
Agent
1
- Name:
- ir. B.Ch. Ledeboer c.s
- From:
- 28/07/2025
- Address:
- V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
- To:
2
- Name:
- ir. H.A. Witmans c.s.
- From:
- 26/11/2019
- Address:
- V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
- To:
- 28/07/2025
Publication
Bulletin
1
- Bulletin Heading:
- SPC
- Journal edition number:
- 23/24
- Publication date:
- 05/06/2024
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
- Bulletin Heading:
- CO
- Journal edition number:
- 22/23
- Publication date:
- 31/05/2023
- Description:
- Changes in the Netherlands Patent Register
3
- Bulletin Heading:
- CO
- Journal edition number:
- 23/22
- Publication date:
- 08/06/2022
- Description:
- Changes in the Netherlands Patent Register
4
- Bulletin Heading:
- SPC
- Journal edition number:
- 32/20
- Publication date:
- 05/08/2020
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
- Bulletin Heading:
- SPC
- Journal edition number:
- 49/19
- Publication date:
- 04/12/2019
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202301010A
- Date Registered:
- 16/05/2023
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. H.A. Witmans c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Takeda Pharmaceuticals U.S.A. Inc.
- Address:
- 95 Hayden Avenue, 02421, Lexington, MA, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202201330A
- Date Registered:
- 25/05/2022
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- Baker & McKenzie Amsterdam N.V.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Takeda Pharmaceutical Company Limited
- Address:
- 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan (JP)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 30/06/2027
- Annual Fee Number:
- 24
- Annual Fee Amount:
- 2200 Euro
- Last Annual Payment Date:
- 20/05/2026
- Last Annual Fee Paid Number:
- 23
- Last Annual Fee Paid Amount:
- 2000 Euro
- Payer:
- Anaqua Services
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 29/07/2020 | Outgoing Correspondence | Decision grant | 2 | /7/5/5/9/8/0800489557/docs/301019_0_357409l504a.pdf | ||
| 29/07/2020 | SPC Documents | Certificate SPC | 1 | /7/5/5/9/8/0800489557/docs/301019_3_supplprotectioncertificate20200901100451245.pdf | ||
| 04/12/2019 | Outgoing Correspondence | Confirmation receipt request | 1 | /7/5/5/9/8/0800489557/docs/301019_7_313801l174.pdf | ||
| 26/11/2019 | Application Form | First filed application form | 3 | /7/5/5/9/8/0800489557/docs/301019_1_applicationform20191203102650607.pdf | ||
| 26/11/2019 | SPC Documents | Summary of the characteristics of the product | 20 | /7/5/5/9/8/0800489557/docs/301019_2_supplprotectioncertificate20191203102650998.pdf | ||
| 26/11/2019 | SPC Documents | Accompanying letter SPC | 2 | /7/5/5/9/8/0800489557/docs/301019_4_supplprotectioncertificate20191203102650789.pdf | ||
| 26/11/2019 | SPC Documents | Marketing Authorization SPC | 5 | /7/5/5/9/8/0800489557/docs/301019_5_supplprotectioncertificate20191203102650934.pdf | ||
| 26/11/2019 | SPC Documents | Marketing Authorization SPC | 1 | /7/5/5/9/8/0800489557/docs/301019_6_supplprotectioncertificate20191203102650862.pdf |